drugset / Trial / NCT00237302

A Comparison of the Efficacy and Safety of Topiramate Versus Placebo in Preventing Migraine Headaches in Children

NCT00237302

Phase 3 Completed 162 enrolled Ortho-McNeil Neurologics, Inc.
RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to assess the safety and efficacy of topiramate as compared to placebo in preventing migraines in children.

Timeline

Start
2001-07
Primary completion
Completion
2003-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 2 mg/kg
Subject Topiramate Small molecule 3 mg/kg

Indications